Indication
Coagadex is indicated for the treatment and prophylaxis of bleeding episodes and for perioperative management in patients with hereditary factor X deficiency. Coagadex is indicated in all age groups.
Loading your page…
Loading your page…
Factor X Deficiency
Marketing Authorisation Holder: Kedrion S.p.A.
EMA Authorisation: 16/03/2016
INN: human coagulation factor X
AI Drug & Interaction Analysis
Free account required
Ask Osler about Coagadex: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.